CPIC Finds Male Breast Cancer Risk Factors
June 2014Dear Get in Front Supporter,
Due to a $2 million decrease in revenue, we are sorry to report that this is the last issue of the In Front eNewsletter until funding permits further production. More than ever, your support is critical to help us continue our groundbreaking cancer prevention research, along with our communications that bring this information to you, the people we serve. Thank you for reading In Front - we encourage you to check CPIC’s press pages often to keep up with our news.
NCI and CPIC Research Confirms Obesity, High BMI, and Hormonal Disorders Contribute to Male Breast Cancer
According to researchers at the National Cancer Institute and CPIC, and other collaborators, men who are obese or who have never had children are at increased risk of developing breast cancer. In addition, this study confirms that men with the chromosomal disorder Klinefelter syndrome are at very high risk of breast cancer; and men who have gynecomastia, a hormonal condition associated with excess estrogen, are also at greater risk of the disease. “By pooling data from 21 participating studies worldwide, we created a unique opportunity to assess risk factors for male breast cancer among a very large group of patients and controls,” said Ann Hsing, Ph.D., study co-author and Chief Scientific Officer at CPIC.
Almost-Sold-Out CPIC 40th Anniversary Event to Include Raffle: Enter Now to Win a $5,000 Shopping Spree at Stephen Silver Fine Jewelry
CPIC’s 40th Anniversary event on June 26, 2014, is almost sold out! Seats are limited, so don’t wait to purchase your tickets. As part of the celebration of CPIC’s four decades of achievements, the evening will include the announcement of a raffle winner (need not be present to win) who will win $5,000 toward a piece of Stephen Silver Fine Jewelry. Raffle tickets are on sale now for $50 each or $100 for three. Submit your entry in the mail by June 24th at noon, online by June 25th at noon, or at the event on June 26th. If you would like another way to join us in celebrating CPIC’s anniversary, please consider contributing to the just-launched Pioneering Prevention Campaign.
CPIC Welcomes Two New Board Trustees
CPIC is again inspiring new leaders. Joy Yi Boatwright is Vice President at Merrill Lynch and a seasoned financial executive with a background in business development and consulting. “We need to learn more about what causes cancer and put resources toward how to prevent it,” says Joy. “Prevention is the side to be on." Marianne Jackson has over 25 years of experience in the human resources field as a senior executive to several well-known Silicon Valley powerhouses. “I have a passion for wellness strategies that truly yield better individual and population health,” says Marianne. “I am so privileged to be part of CPIC's board to support their incredible work in cancer prevention research."
The Pipeline: Studying Early-Life Exposures to Develop Cancer Prevention Strategies for Girls
CPIC Senior Research Scientist Esther M. John, Ph.D. - who will receive the Saul A. Rosenberg, M.D., Research Award at CPIC’s 40th anniversary celebration - has received funding for year three of the LEGACY Girls Study, a multicenter research project in the US and Canada. It is the first study to focus on how early-life exposures - such as physical activity, diet, and environmental factors - influence pubertal development in girls at increased breast cancer risk due to family history. “To date, we’ve enrolled 1,040 girls across the five study sites and are conducting follow-up visits with the girls every six months,” says Dr. John. “This is a landmark study that will help us develop new preventive strategies for breast cancer that can be started at a young age.”
Men's Health and Cancer Awareness: Prostate Cancer
June is Men’s Health/Cancer Awareness Month. In addition to our studies of male breast cancer, CPIC research includes a focus on prostate cancer, the number one cancer in men. Results from CPIC work in this area have pinpointed factors, such as sun exposure, that impact risk of the disease. Our large-scale prostate cancer research collaborations and groundbreaking studies of prostate cancer in non-white populations are helping to advance understanding of why some racial/ethnic groups are at higher risk of developing or dying from prostate cancer.
© Cancer Prevention Institute of California